Showing results (431-440 of 857) with videos related to
Sort By:
Pageof 86
Histopathology|July 29, 2014
Novel use for an EGFR mutation-specific antibody in discriminating lung adenocarcinoma from reactive pneumocyte hyperplasiaTomoyasu Mimori, Saori Kobayashi, Ayako Tanaka, et al.Cancer Medicine|September 15, 2023
Survival and biomarkers for cachexia in non-small cell lung cancer receiving immune checkpoint inhibitorsDaiki Murata, Koichi Azuma, Norikazu Matsuo, et al.Infection and Immunity|November 14, 1997
Interleukin-12 gene expression in human monocyte-derived macrophages stimulated with Mycobacterium bovis BCG: cytokine regulation and effect of NK cellsH Matsumoto, K Suzuki, K Tsuyuguchi, et al.NMC Case Report Journal|October 20, 2022
Two Cases of Monozygotic Twins with Early-onset Isolated (DYT1) Dystonia Effectively Treated with Bilateral Globus Pallidus Internus StimulationYosuke Okazaki, Tatsuya Sasaki, Kouji Kawai, et al.Breast Cancer Research and Treatment|July 4, 2019
The relationship between ring-type dedicated breast PET and immune microenvironment in early breast cancerShinsuke Sasada, Noriyuki Shiroma, Noriko Goda, et al.Surgery Today|April 29, 2010
Survival of patients treated by an autonomic nerve-preserving gastrectomy for early gastric cancerShinsuke Sasada, Motoki Ninomiya, Masahiko Nishizaki, et al.Biochemical and Biophysical Research Communications|November 16, 2001
6-formylpterin intracellularly generates hydrogen peroxide and restores the impaired bactericidal activity of human neutrophilsK Yamashita, T Arai, K Fukuda, et al.Life Sciences|April 9, 2001
Expression of thioredoxin in bleomycin-injured airway epithelium: possible role of protection against bleomycin induced epithelial injuryY Gon, T Sasada, M Matsui, et al.Retrovirology|May 22, 2013
Interferon-α (IFN-α) suppresses HTLV-1 gene expression and cell cycling, while IFN-α combined with zidovudine induces p53 signaling and apoptosis in HTLV-1-infected cellsShuichi Kinpara, Mami Kijiyama, Ayako Takamori, et al.Cancer Chemotherapy and Pharmacology|January 1, 1989
Clinical pharmacology of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in patients with hematologic malignanciesT Ueda, T Nakamura, D Kagawa, et al.Pageof 86